Get started
Rocket Booster Strategy + The #1 Indicator Power Force TeamThis #1 indicator helped me find this stock which is trending on twitter right now honest to you i didnt think i would find it using this indicator but am glad i did.This is why am sharing it with you today. In this video i also show you the rocket booster strategy which is as follows: Step#1-The price has to be above the 50 SMA Step#2-The price has to be above the 200 SMA Step#3-The price should gap up in a trend The last step is very important because it shows you the price correction of the chart you have decided to trade Rocket boost this content to learn more Disclaimer:Trading is risky please learn risk management and profit taking strategies Also feel free to use simulation trading account before you trade with real money
NYSE:KOLong
by lubosi
FEAR PRESENTS A BUYING OPPORTUNITYThe deteriorating sentiment over the last 3 years has created a substantial buying opportunity. The negative sentiment can be attributed to 4 main things- decreased EPS/ Net Income since 2022/2023 (end of COVID $$), increased debt levels post-Seagen acquisition and revenue challenges due to upcoming patent expirations. While these concerns are not unwarranted, it is important to note that Pfizer has been through several patent cliffs before while simultaneously growing dividends . The notable upcoming expirations include the pneumonia shot Prevnar in 2026 and the cancer drugs Ibrance and Xtandi, both in 2027. Pfizer has an exceptional history of capital preservation and therefore will continue to take action to address any potential revenue shortfalls including aggressive cost-cutting measures already in progress. From a valuation perspective, PFE's shiller PE is currently 9.51 or 94% as low as it has been in the last 10 years and also 89% better than 462 companies in the drug manufacturing industry. Seeking Alpha gives PFE a grade of F on Growth, but when looking at the individual characteristics not 1 is below a D and only two are D's, and in aggregate looks much better than SA is portraying with a grade of F. Pfizer should not usually be expected to be a grower as it is a mature company. From a technical standpoint it looks like a double bottom is forming at the bottom of a 12 year trend line. The Price/ FCF and EV/EBITDA ratios have decreased back to 2023 and prior levels indicating it is no longer overvalued as it was in 2024. Reverse DCF based on EPS w/out NRI and an 11% discount rate show thaf Pfizer's fair value is $35.89, indicating a 27% margin of safety. The recent volume shows large-scale buying, probably by institutions. Overall I believe the negative sentiment mostly due to the upcoming patent expiration and the realization of loss of revenue from COVID era $ is currently baked into the price and presents a decent buying opportunity.
NYSE:PFELong
by Jrussell86
Celsius Holdings, Inc. (CELH) – 30-Min Long Trade Setup!📈 🚀 🔹 Asset: CELH – NASDAQ 🔹 Timeframe: 30-Min Chart 🔹 Setup Type: Rising Wedge Breakout (Bullish Bias) 📊 Trade Plan (Long Position) ✅ Entry Zone: Above $34.89 (Breakout Confirmation) ✅ Stop-Loss (SL): Below $33.42 (Trendline & Previous Candle Support) 🎯 Take Profit Targets: 📌 TP1: $36.80 (Key Resistance Level) 📌 TP2: $38.91 (Extended Target / Measured Move) 📊 Risk-Reward Ratio Calculation: 📉 Risk (SL Distance): $34.89 - $33.42 = $1.47 risk per share 📈 Reward to TP1: $36.80 - $34.89 = $1.91 (1.29:1 R/R) 📈 Reward to TP2: $38.91 - $34.89 = $4.02 (2.73:1 R/R) 🔍 Technical Analysis & Strategy 📌 Bullish Breakout of Wedge: Price is pressing against wedge resistance, signaling possible continuation. 📌 Strong Bullish Momentum: Clear uptrend since mid-March, supported by rising volume. 📌 Candle Confirmation Needed: Look for a bullish 30-min close above $34.89 to validate the move. 📌 Support at $33.42: Ideal place to define risk, as it represents the lower wedge trendline. ⚙️ Trade Execution & Risk Management 📊 Volume Confirmation: Strong green volume on breakout is essential. 📉 Trailing Stop Strategy: Once TP1 is hit, move SL to break-even ($34.89) or higher. 💰 Partial Profit Booking Strategy: ✔ Take 50% profits at TP1 ($36.80), and let the rest run toward TP2 ($38.91). ✔ Lock profits by moving SL after TP1 is reached. ⚠️ Breakout Failure Risk ❌ Avoid premature entry – wait for clear breakout candle. ❌ Break below $33.42 invalidates the setup. 🚀 Final Thoughts ✔ Strong bullish structure with clear R/R up to 2.73:1 ✔ Textbook breakout setup from a rising wedge ✔ Ride the trend with proper volume confirmation and disciplined risk 🔗 #CELH #NASDAQ #LongTrade #BreakoutStrategy #SwingTrading #ProfittoPath 📈🔥
NASDAQ:CELHLong
by ProfittoPath
Hims & Hers Health, Inc. (HIMS) – 30-Min Short Trade Setup !📉🚨 🔹 Asset: HIMS – NYSE 🔹 Timeframe: 30-Min Chart 🔹 Setup Type: Rising Trendline Breakdown & Rejection at Resistance 📊 Trade Plan (Short Position) ✅ Entry Zone: Below $37.42 (Breakdown Confirmation) ✅ Stop-Loss (SL): Above $39.83 (Double Resistance & False Breakout Zone) 🎯 Take Profit Targets: 📌 TP1: $34.98 (Major Support Zone) 📌 TP2: $32.16 (Previous Demand/Consolidation Area) 📊 Risk-Reward Ratio Calculation: 📉 Risk (SL Distance): $39.83 - $37.42 = $2.41 risk per share 📈 Reward to TP1: $37.42 - $34.98 = $2.44 (1.01:1 R/R) 📈 Reward to TP2: $37.42 - $32.16 = $5.26 (2.18:1 R/R) 🔍 Technical Analysis & Strategy 📌 Trendline Breakdown Setup: Price broke below a sharp rising trendline after rejection near horizontal resistance. 📌 Bearish Rejection at $38.00–$39.83: Strong seller zone with historical resistance. 📌 Bearish Candlestick Confirmation: Wait for a 30-min close below $37.42 with solid bearish volume for entry. 📌 Confluence at $34.98: Strong support from previous price structure. ⚙️ Trade Execution & Risk Management 📊 Volume Confirmation: Confirm selling volume on breakdown below $37.42. 📉 Trailing Stop Strategy: Move SL to break-even ($37.42) once TP1 ($34.98) is hit. 💰 Partial Profit Booking Strategy: ✔ Book 50% profits at TP1 ($34.98), let rest ride to TP2 ($32.16). ✔ Adjust SL to entry after TP1 is reached to protect capital. ⚠️ Breakdown Failure Risk ❌ Avoid early entry; wait for confirmation. ❌ If price holds above $37.42 and reclaims trendline, setup invalidates. 🚨 Final Thoughts ✔ Bearish rejection and trendline break signal a possible reversal. ✔ Clean 2.18:1 R/R toward TP2 – attractive short opportunity. ✔ Stick to plan, wait for confirmation, and manage risk accordingly. 🔗 #HIMS #NYSE #ShortTrade #TrendlineBreak #SwingTrading #ProfittoPath 📉📊
NYSE:HIMSShort
by ProfittoPath
2
CRM's Rebound Rally!Salesforce Inc. (CRM) is exhibiting potential bullish momentum, with a notable weekly gap around the $260 level. A breakout above the $313.80 level could signal further strength, positioning the stock to target the $349.13 resistance. This trade setup offers an attractive risk-to-reward ratio, with a stop-loss set at $256.16 to manage downside risk.​ The Relative Strength Index (RSI) for CRM was extremely oversold at 24 on March 10th, indicating a potential for a bounce. As of March 17, 2025, the 14-day RSI had risen to 36.22, suggesting improving momentum. ​ Analyst sentiment remains positive, with a consensus rating of "Moderate Buy" among 40 analysts. The average 12-month price target is $375.58, indicating a potential upside of approximately 33.84% from current levels. Price targets range from a low of $243.00 to a high of $440.00, reflecting confidence in the company's growth prospects. ​ Salesforce's continued innovation in artificial intelligence, particularly with the development of Agentforce 2.0, positions the company well for future growth. This AI-driven suite is expected to optimize marketing campaigns and customer service, contributing to revenue expansion. ​ This combination of technical indicators and strong fundamentals supports a bullish outlook for CRM, with a potential move toward the $349.13 resistance level. NYSE:CRM
NYSE:CRMLong
by The_Trading_Mechanic
OH NO GUESS WHAT I FOUND $TSLA HEAD AND SHOULDERThe head and shoulders pattern is a chart formation in technical analysis that signals possible trend reversals, often suggesting a change from a bullish to a bearish trend. It features three peaks: a central "head" that is the highest, flanked by two "shoulders," with a neckline connecting the troughs between these peaks. Tesla's stock is often viewed as a risky investment for several reasons: High Valuation: NASDAQ:TSLA stock price is considered very high compared to traditional car manufacturers, with a much higher price-to-earnings ratio. Market Volatility: The NASDAQ:TLSA price is highly volatile, influenced by factors like CEO Elon Musk's public comments, regulatory changes, and overall market sentiment. Intense Competition: The electric vehicle market is becoming more competitive, with many established and new companies investing heavily in EV technology. Production Issues: Tesla has experienced production and supply chain challenges, which can affect its ability to meet demand and maintain profitability. Regulatory Risks: Changes in government policies and regulations, especially those related to environmental standards and EV incentives, can significantly impact Tesla's business. While these points highlight potential risks, Tesla also has strengths such as strong brand recognition, technological innovation, and leadership in the EV market. It's important to consider both the risks and potential rewards when evaluating Tesla as an investment. SELLL NOW!!!!!
NASDAQ:TSLAShort
by sej4974
2
PLTR Approaching Critical Gamma Level! Reversal or Continuation?Here's an in-depth update on PLTR based on the current 1-hour chart and Gamma Exposure insights. 📈 Technical Analysis (TA): * Current Price Action: PLTR is trading around $96 after a strong bullish move. It is currently consolidating within a green reversal zone, suggesting caution for possible short-term reversals. * Immediate Resistance: The significant gamma resistance (Gamma Wall) is located at $100, which could act as a strong magnet for price action but also a tough barrier for bulls. * Support Levels: Strong support and reversal (red) zone detected around $86, marking an important area for potential bullish continuation if tested again. * Reversal Zones: Price is currently inside the green reversal zone (around $95–$97). Watch closely for signs of weakening momentum or rejection, signaling a possible pullback. 📊 GEX & Options Insights: * Gamma Resistance: Highest positive NET GEX at $100, creating a strong overhead resistance and potential magnet level for bullish scenarios. * Gamma Support: Put support relatively low with notable strength at $75, indicating significant downside protection. * IVR (Implied Volatility Rank): Moderately high at 52%, suggesting elevated premiums—favorable conditions for credit spreads or cautious long options plays. * CALL Dominance: Calls at 42.6% indicate a relatively balanced yet slightly bullish market sentiment. 💡 Trade Recommendations: * Bullish Scenario: Watch for a sustained breakout above the $97 resistance area targeting the key $100 Gamma Wall. Place a conservative stop-loss around $94. * Bearish Scenario: Consider bearish strategies (puts or credit call spreads) if a strong rejection from the current green reversal zone occurs, targeting downside levels near $90–$86. * Neutral/Range Scenario: Ideal conditions to implement neutral options strategies like iron condors or credit spreads between $85 and $100 given the elevated implied volatility. 🛑 Risk Management: * Given PLTR's elevated volatility and proximity to reversal zones, tight risk management with clear stops is essential. Trade wisely and responsibly! Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Always perform your own research and manage your risk appropriately.
NASDAQ:PLTR
by BullBearInsights